BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 77883)

  • 1. Leukocyte-adherence inhibition: a specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T lymphocytes.
    Powell AE; Sloss AM; Smith RN
    J Immunol; 1978 Jun; 120(6):1957-66. PubMed ID: 77883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic specificity and cellular mechanisms in leukocyte adherence inhibition analysis of immunity to simple proteins and hapten-protein conjugates.
    Powell A; Sloss AM; Smith RN; Murrell H
    Cancer Res; 1979 Feb; 39(2 Pt 2):570-5. PubMed ID: 83911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cellular mechanism of leukocyte adherence inhibition.
    Koppi TA; Maluish AE; Halliday WJ
    J Immunol; 1979 Nov; 123(5):2255-60. PubMed ID: 314958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the indirect tube LAI assay in the study of cell-mediated immunity in rats immunized with B77 tumor cells.
    Kalafut F; Hung PM; Novotná L; Klobusická M
    Neoplasma; 1980; 27(5):525-31. PubMed ID: 7015159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of antigen-specific T cell factors with unique "receptors" on the surface of mast cells: demonstration in vitro by an indirect rosetting technique.
    Kops SK; Ratzlaff RE; Meade R; Iverson GM; Askenase PW
    J Immunol; 1986 Jun; 136(12):4515-24. PubMed ID: 2423595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LAI reactivity in rats immunized with tumor cells.
    Pham Manh Hung ; Kalafut F; Novotná L; Koníková E
    Neoplasma; 1980; 27(4):373-7. PubMed ID: 7005699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the mechanism of the leukocyte adherence inhibition test.
    Tong AW; Burger DR; Finke P; Barney C; Vandenbark AA; Vetto RM
    Cancer Res; 1979 Feb; 39(2 Pt 2):597-603. PubMed ID: 367586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte adherence inhibition to myelin basic protein by cancer patients' T-lymphocytes in association with class II major histocompatibility antigens on monocytes.
    Thomson DM; Halliday WJ; Phelan K
    J Natl Cancer Inst; 1985 Dec; 75(6):995-1003. PubMed ID: 2415744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanisms, kinetics and specificity of the leukocyte adherence inhibition test in breast cancer].
    Kharkevich DD; Polevaia EB; Derevnina NA; Sablikova IuA; Savinov AIu
    Eksp Onkol; 1985; 7(6):69-73. PubMed ID: 3910405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell populations in leucocyte adherence inhibition: requirement for T lymphocytes with IgG Fc receptors.
    Powell AE; Birch RE; Murrell H; Sloss AM
    Immunology; 1982 Aug; 46(4):689-96. PubMed ID: 7049907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF).
    Pisko EJ; Foster SL; White RE; Panetti M; Turner RA
    J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro immunization to KLH. II. Limiting dilution analysis of antigen-reactive cells in primary and secondary culture.
    Gebel HM; Scott JR; Parvin CA; Rodey GE
    J Immunol; 1983 Jan; 130(1):29-32. PubMed ID: 6183352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the microplate leukocyte adherence inhibition test and its reproducibility, sensitivity, and relationship to other tests of cellular immunity.
    Holt PG; Fimmel PJ; Finlay-Jones LM; Flower RL
    Cancer Res; 1979 Feb; 39(2 Pt 2):564-9. PubMed ID: 367583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay.
    Borkowsky W; Suleski P; Bhardwaj N; Lawrence HS
    J Immunol; 1981 Jan; 126(1):80-2. PubMed ID: 6161170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays.
    Shenouda G; Thomson DM; MacFarlane JK
    Cancer Res; 1984 Mar; 44(3):1238-45. PubMed ID: 6420056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of thymus-dependent antibody formation in bone marrow.
    Koch G; Osmond DG; Julius MH; Benner R
    J Immunol; 1981 Apr; 126(4):1447-51. PubMed ID: 6162889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the haemocytometer and tube modifications of the leucocyte adherence inhibition assay.
    Holán V; Schimke R; Ambrosius H; Hasek M
    Folia Biol (Praha); 1981; 27(1):66-75. PubMed ID: 6162681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell-mediated immune response of the pig to orally administered antigen.
    Huntley J; Newby TJ; Bourne FJ
    Immunology; 1979 May; 37(1):225-30. PubMed ID: 89079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-4 synthesis by in vivo primed keyhole limpet hemocyanin-specific CD4+ T cells. I. Influence of antigen concentration and antigen-presenting cell type.
    DeKruyff RH; Fang Y; Umetsu DT
    J Immunol; 1992 Dec; 149(11):3468-76. PubMed ID: 1358971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of tumor antigen recognition by T-lymphocytes in the leukocyte adherence inhibition (LAI) assay in patients with breast cancer.
    Tsang PH; Holland JF; Bekesi JG
    J Clin Lab Immunol; 1982 Dec; 9(3):151-7. PubMed ID: 6762442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.